Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

Phibro Animal Health Corporation Financial Results Fiscal Year 2025 Third Quarter Ended March 31, 2025 Webcast and Conference Call May 8, 2025 Webcast and Conference Call May 8, 2025 U.S. toll-free +1.888.330.2022 Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to any future debt and leverage levels. All statements other than statements of historical or current fact included i ...

Phibro Animal Health (PAHC) Q3 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Glenn David - Chief Financial OfficerJack Bendheim - Chairman, President & CEOEkaterina Knyazkova - Equity Research AssociateMichael Ryskin - Managing Director Conference Call Participants Navann Ty Dietschi - Lead Analyst Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Fibro Animal Health Corpora ...

Phibro Animal Health (PAHC) Q3 2025 Earnings Call May 08, 2025 09:00 AM ET Speaker0 Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Fibro Animal Health Corporation Third Quarter twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. I would now like to turn the conferenc ...

Phibro Animal Health (PAHC) delivered adjusted earnings per share (EPS) of 63 cents in the third quarter of fiscal 2025 compared with 31 cents in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 21.1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar).Without adjustments, GAAP EPS in the quarter was 51 cents compared with 21 cents in the prior-year period.PAHC’s Q3 RevenuesNet sales in the quarter totaled $347.8 million, up 23.8% from the year-ago quarter’s l ...

Phibro Animal Health (PAHC) reported $347.8 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 32.1%. EPS of $0.63 for the same period compares to $0.31 a year ago.The reported revenue represents a surprise of -0.78% over the Zacks Consensus Estimate of $350.54 million. With the consensus EPS estimate being $0.52, the EPS surprise was +21.15%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Phibro Animal Health (PAHC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.15%. A quarter ago, it was expected that this maker of animal health products and nutritional supplements would post earnings of $0.42 per share when it actually produced earnings of $0.54, delivering a sur ...

Exhibit 99.1 For Immediate Release Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance QUARTERLY RESULTS TEANECK, N.J., May 7, 2025 (Business Wire) – Phibro Animal Health Corporation (Nasdaq: PAHC) ("Phibro" or the "Company") today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 13-184 ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that t ...